CSIMarket
 


Seagen Inc   (SGEN)
Other Ticker:  
 
 

SGEN's Revenue Growth by Quarter and Year

Seagen Inc 's Revenue results by quarter and year




SGEN Revenue (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - 528.15 429.85 601.29
III Quarter September 648.65 510.30 424.06 1,061.73
II Quarter June 603.83 497.50 388.48 278.00
I Quarter March 519.72 426.46 331.98 234.51
FY   1,772.20 1,962.41 1,574.37 2,175.53



SGEN Revenue third quarter 2023 Y/Y Growth Comment
Seagen Inc reported Revenue improvement of 27.11% year on year in the third quarter 2023, to $ 648.65 millions, this is lower than Seagen Inc 's recent average Revenue improvement of 29.35%.

Looking into third quarter 2023 results within Biotechnology & Pharmaceuticals industry 5 other companies have achieved higher Revenue growth. While Seagen Inc ' s Revenue rise of 27.11% ranks overall at the positon no. 736 in the third quarter 2023.




SGEN Revenue ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - 22.87 % -28.51 % 107.48 %
III Quarter September 27.11 % 20.34 % -60.06 % 397.86 %
II Quarter June 21.37 % 28.06 % 39.74 % 27.26 %
I Quarter March 21.87 % 28.46 % 41.56 % 20.14 %
FY   - 24.65 % -27.63 % 137.32 %

Financial Statements
Seagen Inc 's third quarter 2023 Revenue $ 648.65 millions SGEN's Income Statement
Seagen Inc 's third quarter 2022 Revenue $ 510.30 millions Quarterly SGEN's Income Statement
New: More SGEN's historic Revenue Growth >>


SGEN Revenue (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - 3.5 % 1.37 % -43.37 %
III Quarter September 7.42 % 2.57 % 9.16 % 281.92 %
II Quarter June 16.18 % 16.66 % 17.02 % 18.55 %
I Quarter March -1.6 % -0.79 % -44.79 % -19.08 %
FY (Year on Year)   - 24.65 % -27.63 % 137.32 %




Revenue third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #6
Healthcare Sector #87
Overall #736

Revenue Y/Y Growth Statistics
High Average Low
137.76 % 29.35 % -27.63 %
(Mar 31 2021)   (Dec 31 2021)
Revenue third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #6
Healthcare Sector #87
Overall #736
Revenue Y/Y Growth Statistics
High Average Low
137.76 % 29.35 % -27.63 %
(Mar 31 2021)   (Dec 31 2021)

Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Seagen Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
281.92 % 10.19 % -44.79 %
(Sep 30 2020)  


SGEN's III. Quarter Q/Q Revenue Comment
Seagen Inc achieved in the III. Quarter 2023 below company average Revenue increase of 7.42% quarter on quarter, to $ 648.65 millions.

III. Quarter 2023 SGEN's performance were paradoxical, although beneath the regular growth of 10.19 %, yet it demonstrates real acceleration relative to the 2.57% in the III. Quarter a year ago.

Within Biotechnology & Pharmaceuticals industry 9 other companies have achieved higher Revenue quarter on quarter growth. While Seagen Inc 's Revenue growth quarter on quarter, overall rank is 286.


Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #10
Healthcare Sector #48
Overall #286
Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #10
Healthcare Sector #48
Overall #286
Revenue Q/Q Growth Statistics
High Average Low
281.92 % 10.19 % -44.79 %
(Sep 30 2020)  


SGEN's III. Quarter Q/Q Revenue Comment
Seagen Inc achieved in the III. Quarter 2023 below company average Revenue increase of 7.42% quarter on quarter, to $ 648.65 millions.

III. Quarter 2023 Revenue sequential growth seem to be paradoxical, albeit beneath the regular, yet it demonstrates absolute acceleration measured to the 2.57% in the III. Quarter 2022 Cristina Sanz, a business observer mentioned.

Within Biotechnology & Pharmaceuticals industry 9 other companies have achieved higher Revenue quarter on quarter growth. While Seagen Inc 's Revenue growth quarter on quarter, overall rank is 286.


Seagen Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
Cumulative Revenue 12 Months Ending $ 2,300.35 $ 2,162.00 $ 2,055.67 $ 1,962.41 $ 1,864.11
Y / Y Revenue Growth (TTM) 23.4 % 21.61 % 23.18 % 24.65 % 6.78 %
Year on Year Revenue Growth Overall Ranking # 1627 # 744 # 3346 # 2213 # 270
Seqeuential Revenue Change (TTM) 6.4 % 5.17 % 4.75 % 5.27 % 4.85 %
Seq. Revenue Growth (TTM) Overall Ranking # 1794 # 431 # 2078 # 2062 # 96




Cumulative Revenue growth Comment
Although Seagen Inc 's Annual Revenue growth year on year were below company's average 29.35% , Revenue announced in the Sep 30 2023 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 23.4% year on year, from 21.61% in Jun 30 2023.

In the Healthcare sector 288 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 744 to 1627.

Revenue TTM Q/Q Growth Statistics
High Average Low
137.76 %
29.35 %
-27.63 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 29
Healthcare Sector # 289
Overall # 1627

Revenue TTM Y/Y Growth Statistics
High Average Low
137.76 %
29.35 %
-27.63 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 29
Sector # 306
S&P 500 # 1794
Cumulative Revenue growth Comment
Although Seagen Inc 's Annual Revenue growth year on year were below company's average 29.35% , Revenue announced in the Sep 30 2023 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 23.4% year on year, from 21.61% in Jun 30 2023.

In the Healthcare sector 288 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 744 to 1627.

Revenue TTM Q/Q Growth Statistics
High Average Low
137.76 %
29.35 %
-27.63 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 29
Healthcare Sector # 289
Overall # 1627

Revenue TTM Y/Y Growth Statistics
High Average Low
137.76 %
29.35 %
-27.63 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 29
Sector # 306
S&P 500 # 1794




Other Revenue Growth
Biotechnology & Pharmaceuticals Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
SGEN's Revenue Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for SGEN's Competitors
Revenue Growth for Seagen Inc 's Suppliers
Revenue Growth for SGEN's Customers

You may also want to know
SGEN's Annual Growth Rates SGEN's Profitability Ratios SGEN's Asset Turnover Ratio SGEN's Dividend Growth
SGEN's Roe SGEN's Valuation Ratios SGEN's Financial Strength Ratios SGEN's Dividend Payout Ratio
SGEN's Roa SGEN's Inventory Turnover Ratio SGEN's Growth Rates SGEN's Dividend Comparisons



Companies with similar Revenue increase for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %Revenue for the quarter ending Sep 30 2023
Neuropace Inc 45.50%$ 45.496 millions
Sarepta Therapeutics Inc 44.10%$ 44.100 millions
Igc Pharma Inc 44.06%$ 44.059 millions
Shockwave Medical Inc 41.25%$ 41.253 millions
Aadi Bioscience Inc 40.38%$ 40.377 millions
Inspire Medical Systems inc 40.05%$ 40.052 millions
Omega Therapeutics Inc 39.66%$ 39.664 millions
Janux Therapeutics Inc 38.83%$ 38.831 millions
Viemed Healthcare Inc 38.15%$ 38.153 millions
Mersana Therapeutics Inc 38.13%$ 38.130 millions
Eli Lilly And Company36.84%$ 36.836 millions
Progyny Inc 36.64%$ 36.642 millions
Harmony Biosciences Holdings inc 36.49%$ 36.488 millions
Lantheus Holdings Inc 33.29%$ 33.289 millions
Lifeloc Technologies Inc 32.66%$ 32.662 millions
Nephros Inc 32.59%$ 32.586 millions
Alphatec Holdings Inc 31.40%$ 31.398 millions
Axonics Inc 30.86%$ 30.859 millions
Inari Medical Inc 30.86%$ 30.856 millions
Rockwell Medical inc 30.52%$ 30.517 millions
Tela Bio Inc 30.05%$ 30.052 millions
Rapid Micro Biosystems Inc 29.67%$ 29.669 millions
Ontrak Inc 29.26%$ 29.265 millions
Adaptimmune Therapeutics Plc29.15%$ 29.150 millions
Bionano Genomics Inc 29.04%$ 29.040 millions
Talkspace Inc 29.04%$ 29.037 millions
Akoya Biosciences Inc 28.77%$ 28.771 millions
Neurocrine Biosciences Inc 28.59%$ 28.590 millions
Si bone inc 28.53%$ 28.530 millions
Medpace Holdings Inc 28.34%$ 28.341 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com